世界の薄膜医薬品製造市場(製品-口腔薄膜(舌下フィルム、歯科/口腔フィルムの完全溶解)、経皮薄膜;疾患-統合失調症、偏頭痛、オピオイド依存症、悪心、嘔吐;流通経路-病院薬局、薬物ストア、小売薬局、電子商取引)-グローバル産業分析、規模、シェア、成長、動向及び予測2016ー2024

【英語タイトル】Thin Film Drug Manufacturing Market (Product - Oral Thin Film (Sublingual Film and Fully Dissolving Dental/Buccal Film), and Transdermal Thin Film; Disease Indication - Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting; Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Transparency Market Researchが出版した調査資料(TMR706003)・商品コード:TMR706003
・発行会社(調査会社):Transparency Market Research
・発行日:2017年5月30日
・ページ数:197
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥654,835見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥993,835見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算¥1,332,835見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界の薄膜医薬品製造市場について調査・分析し、産業分析、世界の薄膜医薬品製造市場規模、市場シェア、成長、市場動向、予測データを含め、以下の構成でお届けいたします。
・世界の薄膜医薬品製造市場:序文
・世界の薄膜医薬品製造市場:エグゼクティブサマリー
・世界の薄膜医薬品製造市場:市場概要・動向
・世界の薄膜医薬品製造市場:セグメント別市場規模・分析
・世界の薄膜医薬品製造市場:地域別市場規模・分析
・世界の薄膜医薬品製造市場:関連企業分析
【レポートの概要】

Global Thin Film Drug Manufacturing Market: Overview

This report on thin film drug manufacturing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of thin film drug manufacturing products such as oral thin film, transdermal thin film and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thin film drug manufacturing market with respect to the leading market segments based on major disease indication segment, products segment, distribution channels, and geographies.

Global Thin Film Drug Manufacturing Market: Segmentation

Based on the product type, the thin film drug manufacturing market has been segmented into: oral thin film, transdermal thin film and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thin film drug manufacturing products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Thin Film Drug Manufacturing Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thin film drug manufacturing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thin film drug manufacturing market.

Global Thin Film Drug Manufacturing Market: Regional Outlook

Geographically, thin film drug manufacturing market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East and Africa. The market size and forecast for each of these regions has been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thin film drug manufacturing market.

Key Players Mentioned in this Report are:

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global thin film drug manufacturing market. The report also profiles key players operating in the thin film drug manufacturing market which are Pfizer, Inc., Novartis AG, Allergan plc, Wolters Kluwer, Solvay, IntelGenx Corp., Sumitomo Dainippon Pharma Co., Ltd., Indivior plc and ZIM Laboratories Limited

The global thin film drug manufacturing market is segmented as follows:

Global Thin Film Drug Manufacturing Market, by Product Type

Oral Thin Film
Sublingual Film
Fully Dissolving Dental/Buccal Film
Transdermal Thin Film
Others (ocular thin film, etc.)
Global Thin Film Drug Manufacturing Market, by Disease Indication

Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Global Thin Film Drug Manufacturing Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of the Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
South Africa
Saudi Arebia
UAE
Rest of MEA

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Thin Film Drug Manufacturing Analysis and Forecasts, 2016–2024
4.6. Thin Film Drug Manufacturing – Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook

5. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product, 2016–2024
5.4.1. Oral Thin Film
5.4.1.1. Sublingual film
5.4.1.2. Fully dissolving dental/ buccal film
5.4.2. Transdermal Thin Film
5.4.3. Others
5.5. Product Comparison Matrix
5.6. Market Attractiveness By Product
5.7. Oral Thin Film Drugs : Key market insights
5.7.1. Pipeline Analysis
5.7.2. Technology Insights
5.7.3. Key Product Insights

6. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast By Distribution Channel, 2016–2024
6.3.1. Hospital Pharmacies
6.3.2. Drug Stores
6.3.3. Retail Pharmacies
6.3.4. E- Commerce
6.4. Distribution Channel Comparison Matrix
6.5. Market Attractiveness By Distribution Channel

7. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Disease Indication
7.1. Introduction & Definition
7.2. Key Findings
7.3. Key Trends
7.4. Market Value Forecast By Disease Indication, 2016–2024
7.4.1. Schizophrenia
7.4.2. Migraine
7.4.3. Opioid Dependence
7.4.4. Nausea & Vomiting
7.4.5. Others
7.5. Disease Indication Comparison Matrix
7.6. Market Attractiveness By Disease Indication

8. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Region
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Asia Pacific
8.3.4. Europe
8.3.5. Middle East & Africa
8.4. Market Attractiveness By Country/Region

9. North America Thin Film Drug Manufacturing Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast By Product, 2016–2024
9.2.1. Oral Thin Film
9.2.1.1. Sublingual film
9.2.1.2. Fully dissolving dental/ buccal film
9.2.2. Transdermal Thin Film
9.2.3. Others (Ocular Thin Film, etc.)
9.3. Market Value Forecast By Distribution Channel, 2016–2024
9.3.1. Hospital Pharmacies
9.3.2. Drug Stores
9.3.3. Retail Pharmacies
9.3.4. E- Commerce
9.4. Market Value Forecast By Disease Indication, 2016–2024
9.4.1. Schizophrenia
9.4.2. Migraine
9.4.3. Opioid Dependence
9.4.4. Nausea & Vomiting
9.4.5. Others
9.5. Market Value Forecast By Country, 2016–2024
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Distribution Channel
9.6.3. By Disease Indication
9.6.4. By Country

10. Latin America Thin Film Drug Manufacturing Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast By Product, 2016–2024
10.2.1. Oral Thin Film
10.2.1.1. Sublingual film
10.2.1.2. Fully dissolving dental/ buccal film
10.2.2. Transdermal Thin Film
10.2.3. Others (Ocular Thin Film, etc.)
10.3. Market Value Forecast By Distribution Channel, 2016–2024
10.3.1. Hospital Pharmacies
10.3.2. Drug Stores
10.3.3. Retail Pharmacies
10.3.4. E- Commerce
10.4. Market Value Forecast By Disease Indication, 2016–2024
10.4.1. Schizophrenia
10.4.2. Migraine
10.4.3. Opioid Dependence
10.4.4. Nausea & Vomiting
10.4.5. Others
10.5. Market Value Forecast By Country, 2016–2024
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Distribution Channel
10.6.3. By Disease Indication
10.6.4. By Country

11. Asia Pacific Thin Film Drug Manufacturing Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast By Product, 2016–2024
11.2.1. Oral Thin Film
11.2.1.1. Sublingual film
11.2.1.2. Fully dissolving dental/ buccal film
11.2.2. Transdermal Thin Film
11.2.3. Others (Ocular Thin Film, etc.)
11.3. Market Value Forecast By Distribution Channel, 2016–2024
11.3.1. Hospital Pharmacies
11.3.2. Drug Stores
11.3.3. Retail Pharmacies
11.3.4. E- Commerce
11.4. Market Value Forecast By Disease Indication, 2016–2024
11.4.1. Schizophrenia
11.4.2. Migraine
11.4.3. Opioid Dependence
11.4.4. Nausea & Vomiting
11.4.5. Others
11.5. Market Value Forecast By Country, 2016–2024
11.5.1. Japan
11.5.2. India
11.5.3. China
11.5.4. Rest Of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Distribution Channel
11.6.3. By Disease Indication
11.6.4. By Country

12. Europe Thin Film Drug Manufacturing Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast By Product, 2016–2024
12.2.1. Oral Thin Film
12.2.1.1. Sublingual film
12.2.1.2. Fully dissolving dental/ buccal film
12.2.2. Transdermal Thin Film
12.2.3. Others (Ocular Thin Film, etc.)
12.3. Market Value Forecast By Distribution Channel, 2016–2024
12.3.1. Hospital Pharmacies
12.3.2. Drug Stores
12.3.3. Retail Pharmacies
12.3.4. E- Commerce
12.4. Market Value Forecast By Disease Indication, 2016–2024
12.4.1. Schizophrenia
12.4.2. Migraine
12.4.3. Opioid Dependence
12.4.4. Nausea & Vomiting
12.4.5. Others
12.5. Market Value Forecast By Country, 2016–2024
12.5.1. France
12.5.2. Germany
12.5.3. Italy
12.5.4. Spain
12.5.5. Russia
12.5.6. Rest Of Europe
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.6.3. By Disease Indication
12.6.4. By Country

13. Middle East & Africa Thin Film Drug Manufacturing Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast By Product, 2016–2024
13.2.1. Oral Thin Film
13.2.1.1. Sublingual film
13.2.1.2. Fully dissolving dental/ buccal film
13.2.2. Transdermal Thin Film
13.2.3. Others (Ocular Thin Film, etc.)
13.3. Market Value Forecast By Distribution Channel, 2016–2024
13.3.1. Hospital Pharmacies
13.3.2. Drug Stores
13.3.3. Retail Pharmacies
13.3.4. E- Commerce
13.4. Market Value Forecast By Disease Indication, 2016–2024
13.4.1. Schizophrenia
13.4.2. Migraine
13.4.3. Opioid Dependence
13.4.4. Nausea & Vomiting
13.4.5. Others
13.5. Market Value Forecast By Country, 2016–2024
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. UAE
13.5.4. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Distribution Channel
13.6.3. By Disease Indication
13.6.4. By Country

14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.2.1. ZIM Laboratories Limited
14.2.1.1. Company Details
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Indivior plc.
14.2.2.1. Company Details
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. MonoSol Rx Allergan plc.
14.2.3.1. Company Details
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
14.2.4.1. Company Details
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. IntelGenx Corp
14.2.5.1. Company Details
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Pfizer, Inc.
14.2.6.1. Company Details
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Novartis AG
14.2.7.1. Company Details
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Allergan plc.
14.2.8.1. Company Details
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. NAL Pharma
14.2.9.1. Company Details
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Wolters Kluwer
14.2.10.1. Company Details
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Solvay
14.2.11.1. Company Details
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis

List of Figures

Figure 01: Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2016–2024
Figure 03: Market Value Share (%), by Disease Indication (2015)
Figure 05: Market Value Share (%), by Region (2015)
Figure 02: Market Value Share (%), by Product Type (2015)
Figure 04: Market Value Share (%), by Distribution Channel (2015)
Figure 06: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Oral Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 08: Global Transdermal Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 09: Global others (ocular thin film, etc.) Market Revenue (US$ Mn), 2014–2024
Figure 10: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2014–2024



★調査レポート[世界の薄膜医薬品製造市場(製品-口腔薄膜(舌下フィルム、歯科/口腔フィルムの完全溶解)、経皮薄膜;疾患-統合失調症、偏頭痛、オピオイド依存症、悪心、嘔吐;流通経路-病院薬局、薬物ストア、小売薬局、電子商取引)-グローバル産業分析、規模、シェア、成長、動向及び予測2016ー2024] (コード:TMR706003)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の薄膜医薬品製造市場(製品-口腔薄膜(舌下フィルム、歯科/口腔フィルムの完全溶解)、経皮薄膜;疾患-統合失調症、偏頭痛、オピオイド依存症、悪心、嘔吐;流通経路-病院薬局、薬物ストア、小売薬局、電子商取引)-グローバル産業分析、規模、シェア、成長、動向及び予測2016ー2024]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆